fulvestrant

Generic: fulvestrant

Labeler: bluepoint laboratories
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name fulvestrant
Generic Name fulvestrant
Labeler bluepoint laboratories
Dosage Form INJECTION
Routes
INTRAMUSCULAR
Active Ingredients

fulvestrant 250 mg/5mL

Manufacturer
BluePoint Laboratories

Identifiers & Regulatory

Product NDC 68001-522
Product ID 68001-522_e4b34fb8-f651-8d00-e053-2995a90a3d2a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211689
Listing Expiration 2026-12-31
Marketing Start 2021-10-29

Pharmacologic Class

Established (EPC)
estrogen receptor antagonist [epc]
Mechanism of Action
estrogen receptor antagonists [moa] selective estrogen receptor modulators [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68001522
Hyphenated Format 68001-522

Supplemental Identifiers

RxCUI
727762
UPC
0368001522861
UNII
22X328QOC4
NUI
N0000175582 N0000000145 N0000000168

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name fulvestrant (source: ndc)
Generic Name fulvestrant (source: ndc)
Application Number ANDA211689 (source: ndc)
Routes
INTRAMUSCULAR
source: ndc

Resolved Composition

Strengths
  • 250 mg/5mL
source: ndc
Packaging
  • 2 SYRINGE, GLASS in 1 CARTON (68001-522-85) / 5 mL in 1 SYRINGE, GLASS (68001-522-86)
source: ndc

Packages (1)

68001-522-85 2 SYRINGE, GLASS in 1 CARTON (68001-522-85) / 5 mL in 1 SYRINGE, GLASS (68001-522-86)

Ingredients (1)

fulvestrant (250 mg/5mL)

Linked Drug Pages (1)

FULVESTRANT ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR"], "spl_id": "e4b34fb8-f651-8d00-e053-2995a90a3d2a", "openfda": {"nui": ["N0000175582", "N0000000145", "N0000000168"], "upc": ["0368001522861"], "unii": ["22X328QOC4"], "rxcui": ["727762"], "spl_set_id": ["477098a1-cd37-48ad-b17f-aef610cb0f57"], "pharm_class_epc": ["Estrogen Receptor Antagonist [EPC]"], "pharm_class_moa": ["Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE, GLASS in 1 CARTON (68001-522-85)  / 5 mL in 1 SYRINGE, GLASS (68001-522-86)", "package_ndc": "68001-522-85", "marketing_start_date": "20211029"}], "brand_name": "FULVESTRANT", "product_id": "68001-522_e4b34fb8-f651-8d00-e053-2995a90a3d2a", "dosage_form": "INJECTION", "pharm_class": ["Estrogen Receptor Antagonist [EPC]", "Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "product_ndc": "68001-522", "generic_name": "Fulvestrant", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "FULVESTRANT", "active_ingredients": [{"name": "FULVESTRANT", "strength": "250 mg/5mL"}], "application_number": "ANDA211689", "marketing_category": "ANDA", "marketing_start_date": "20211029", "listing_expiration_date": "20261231"}